PAE could reduce the excessive testosterone in theca cells through downregulation of CYP17A1 and CYP11A1, which provided scientific evidence for the treatment of ovarian hyperandrogenism with PAE [31]. The gene discussed is CYP17A1; the disease is Ovarian Hyperandrogenism.